Emily Field
Stock Analyst at Barclays
(3.15)
# 2,510
Out of 4,575 analysts
825
Total ratings
46.6%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Rated: Buy | $1,400 | $1,196.03 | +17.05% | 21 | Jul 17, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $131.07 | +6.81% | 9 | Jun 26, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $259.36 | +6.03% | 9 | Jun 26, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $24.54 | +1.87% | 5 | Jun 15, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $75 | $62.09 | +20.79% | 6 | Jun 2, 2026 | |
| BIIB Biogen | Reiterated: Hold | $185 | $202.19 | -8.50% | 5 | May 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $350 | $376.04 | -6.92% | 6 | May 5, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $155 | $129.31 | +19.87% | 3 | Apr 21, 2026 | |
| CYTK Cytokinetics | Rated: Buy | $95 | $80.74 | +17.66% | 7 | Apr 6, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $51.35 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $155.01 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.35 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $54.70 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | CHF 355.10 | -22.56% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | 1,920p | -24.46% | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | €76.03 | +38.10% | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | CHF 63.62 | -13.55% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | kr 320.60 | +16.97% | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | 12,670p | +10.50% | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | €24.50 | -10.20% | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | CHF 126.90 | n/a | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | €46.06 | n/a | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | 1,582p | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | kr 1,877 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | €139.15 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | €815.30 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | €9.66 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | €158.40 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | €240.88 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $143 → $125 | $27.84 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52.68 | $17.54 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.000001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33 | $7.58 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
Jul 17, 2026
Rated: Buy
Price Target: $1,400
Current: $1,196.03
Upside: +17.05%
Merck & Co.
Jun 26, 2026
Maintained: Buy
Price Target: $140
Current: $131.07
Upside: +6.81%
AbbVie
Jun 26, 2026
Maintained: Buy
Price Target: $275
Current: $259.36
Upside: +6.03%
Pfizer
Jun 15, 2026
Maintained: Sell
Price Target: $25
Current: $24.54
Upside: +1.87%
Bristol-Myers Squibb Company
Jun 2, 2026
Maintained: Buy
Price Target: $75
Current: $62.09
Upside: +20.79%
Biogen
May 14, 2026
Reiterated: Hold
Price Target: $185
Current: $202.19
Upside: -8.50%
Amgen
May 5, 2026
Maintained: Hold
Price Target: $350
Current: $376.04
Upside: -6.92%
Gilead Sciences
Apr 21, 2026
Maintained: Hold
Price Target: $155
Current: $129.31
Upside: +19.87%
Cytokinetics
Apr 6, 2026
Rated: Buy
Price Target: $95
Current: $80.74
Upside: +17.66%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $51.35
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $155.01
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.35
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $54.70
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: CHF 355.10
Upside: -22.56%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: 1,920p
Upside: -24.46%
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: €76.03
Upside: +38.10%
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: CHF 63.62
Upside: -13.55%
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: kr 320.60
Upside: +16.97%
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: 12,670p
Upside: +10.50%
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: €24.50
Upside: -10.20%
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: CHF 126.90
Upside: n/a
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: €46.06
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: 1,582p
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: kr 1,877
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: €139.15
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: €815.30
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: €9.66
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: €158.40
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: €240.88
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $143 → $125
Current: $27.84
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $52.68
Current: $17.54
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.000001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: $33
Current: $7.58
Upside: n/a